MD Anderson and Lion Biotechnologies announce strategic alliance to conduct clinical trials of TILs
HOUSTON and SAN CARLOS, Calif. - The University of Texas MD Anderson Cancer Center and Lion Biotechnologies, Inc., a biotechnology company developing novel cancer immunotherapies...








